Profile
Hong Tao Lu is the founder of Elpiscience Biopharma Ltd., serving as Director & Chief Scientific Officer since 2017.
Dr. Lu is the founder of Elpiscience Biopharmaceuticals, Inc., serving as Chief Scientific Officer & Executive Director since 2017.
Dr. Lu is also the founder of Zai Lab Ltd. Former job includes Senior Director-Neuroimmunology Discovery at GlaxoSmithKline (China) R&D Co., Ltd. Education includes a doctorate from Cleveland State University, conferred in 1996, and an undergraduate degree from Xiamen University, conferred in 1987.
Hong Tao Lu active positions
| Companies | Position | Start |
|---|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Founder | 01/01/2017 |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients | Founder | 01/06/2017 |
Former positions of Hong Tao Lu
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline (China) R&D Co., Ltd. | Corporate Officer/Principal | - |
| ZAI LAB LIMITED | Founder | - |
Training of Hong Tao Lu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cleveland State University
Cleveland State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xiamen University
Xiamen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
GlaxoSmithKline (China) R&D Co., Ltd. | |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients | Health Technology |
- Stock Market
- Insiders
- Hong Tao Lu
















